Rediff Eye Drops
By Rediff
Rx
10ml Ophthalmic Solution in a Packet

Composition
Naphazoline(0.0056% w/v) + Chlorpheniramine Maleate(0.01% w/v) + Boric Acid(1.25% w/v) + Sodium Chloride(0.05% w/v) + Hydroxypropylmethylcellulose(0.006% w/v)

Manufacturer - Sunways India Pvt Ltd
1002-1003, 10th Floor, Windfall, Sahar Plaza, J.B.Nagar, Andheri-Kurla Road, Andheri (East), Mumbai-400059. Maharashtra, India.

Expires on or after
April, 2026

liver
For the safety of your liver while using Rediff Eye Drops, it's important to note that no interactions have been found or established related to liver issues. This means that there are currently no known safety concerns or risks specifically concerning the liver when using these eye drops. It is still advisable to exercise caution while using any medication and consult with your doctor if you have any underlying liver issues. Always follow the recommended dosage and instructions provided to ensure the safe use of Rediff Eye Drops.

kidney
No interaction or specific safety advice regarding kidney issues has been established for Rediff Eye Drops. Consult with your doctor for proper guidance before using Rediff Eye Drops.

alcohol
As per the available information, no interactions have been found or established between alcohol and Rediff Eye Drops. It is always advisable to consult with a healthcare provider before consuming alcohol with any medication. if you are pregnant, consult your healthcare provider before using Rediff Eye Drops.

driving
After using Rediff Eye Drops, your vision might be blurry for a short period. Avoid driving until your vision is clear.

pregnancy
It is recommended to consult with your doctor before using Rediff Eye Drops during pregnancy as there is no specific safety information available.

breastfeeding
It is better to consult your doctor before using Rediff Eye Drops.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹61
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025